Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Rapid Diagnostic Testing 2022 - SARS-CoV-2 & Beyond

Rapid Diagnostic Testing 2022 - SARS-CoV-2 & Beyond

Date: Monday, 21 March 2022 - Tuesday, 22 March 2022
Location: Boston

Keynote Speakers

Peter Ertl

Peter Ertl
Professor of Lab-on-a-Chip Systems, Vienna University of Technology

Steve Soper

Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas

Mickey Urdea

Mickey Urdea
Founding Partner & Principal, Halteres Associates

Paul Yager

Paul Yager
Professor, Department of Bioengineering, University of Washington and CSO, UbiDX, Inc.

Danilo Tagle

Danilo Tagle
Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)

Joanna Sickler

Joanna Sickler
Head of Healthcare Systems Policy, Roche Diagnostics


SelectBIO welcomes you to the Rapid Diagnostic Testing 2022: SARS-CoV-2 and Beyond Conference to be held on-site in Boston as a regular conference with on-site participants.

This conference brings together researchers from academic institutions and industry who are involved in developing technologies and tools to enable rapid testing at the point-of-care setting.  The ongoing COVID-19 pandemic provides a paradigm for deployment of these tools for rapid testing and drives the need for technology developments in this space.

Participants will address emerging tools and companies developing tools present their tools and approaches.

Professor Peter Ertl will be serving as Conference Chairperson and the format of the conference will include scientific presentations as well as presentations from companies as well as discussions and networking with participants from other co-located conference tracks.

All attendees receive full access to all co-located and concurrent tracks for maximal scientific exchanges and networking opportunities.

The conference is held on-site in Boston as a regular conference with on-site participants and proof of vaccination against COVID-19 is required to attend the event on-site.

Agenda Topics

  • Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
  • Lateral Flow Assays
  • Nucleic Acid Diagnostic Tests and Rapid Testing: Evolution of the Space
  • Rapid Biodetection of Pathogens and Threat Identification: Pandemics and Biosurveillance
  • SARS-CoV-2 Rapid Diagnostics and Global Health

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager

Exhibition Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2022-03-21 00:00:002022-03-22 00:00:00Europe/LondonRapid Diagnostic Testing 2022 - SARS-CoV-2 and BeyondRapid Diagnostic Testing 2022 - SARS-CoV-2 and Beyond in